25 XP   0   0   10

Shanxi C&Y Pharmaceutical Group Co Ltd
Buy, Hold or Sell?

Let's analyse Shanxi C&Y Pharmaceutical Group Co Ltd together

PenkeI guess you are interested in Shanxi C&Y Pharmaceutical Group Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shanxi C&Y Pharmaceutical Group Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Shanxi C&Y Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Shanxi C&Y Pharmaceutical Group Co Ltd.

Quick analysis of Shanxi C&Y Pharmaceutical Group Co Ltd (30 sec.)










What can you expect buying and holding a share of Shanxi C&Y Pharmaceutical Group Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.22
Expected worth in 1 year
¥4.03
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
¥1.03
Return On Investment
11.4%

For what price can you sell your share?

Current Price per Share
¥9.00
Expected price per share
¥4.98 - ¥11.60
How sure are you?
50%

1. Valuation of Shanxi C&Y Pharmaceutical Group Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥9.00

Intrinsic Value Per Share

¥-0.05 - ¥4.80

Total Value Per Share

¥3.17 - ¥8.02

2. Growth of Shanxi C&Y Pharmaceutical Group Co Ltd (5 min.)




Is Shanxi C&Y Pharmaceutical Group Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$107.5m$100.7m$6.7m6.3%

How much money is Shanxi C&Y Pharmaceutical Group Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$3.4m-$16.3m$19.8m570.4%
Net Profit Margin3.2%-14.3%--

How much money comes from the company's main activities?

3. Financial Health of Shanxi C&Y Pharmaceutical Group Co Ltd (5 min.)




What can you expect buying and holding a share of Shanxi C&Y Pharmaceutical Group Co Ltd? (5 min.)

Welcome investor! Shanxi C&Y Pharmaceutical Group Co Ltd's management wants to use your money to grow the business. In return you get a share of Shanxi C&Y Pharmaceutical Group Co Ltd.

What can you expect buying and holding a share of Shanxi C&Y Pharmaceutical Group Co Ltd?

First you should know what it really means to hold a share of Shanxi C&Y Pharmaceutical Group Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Shanxi C&Y Pharmaceutical Group Co Ltd is ¥9. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shanxi C&Y Pharmaceutical Group Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shanxi C&Y Pharmaceutical Group Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.22. Based on the TTM, the Book Value Change Per Share is ¥0.20 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.06 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shanxi C&Y Pharmaceutical Group Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.2%0.010.2%-0.07-0.8%-0.05-0.6%-0.02-0.2%
Usd Book Value Change Per Share0.030.3%0.030.3%-0.01-0.1%-0.02-0.2%0.000.0%
Usd Dividend Per Share0.010.1%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.040.4%0.040.4%0.000.0%-0.01-0.1%0.010.1%
Usd Price Per Share1.33-1.33-0.93-1.11-1.89-
Price to Earnings Ratio92.35-92.35--13.80-83.84-142.71-
Price-to-Total Gains Ratio37.50-37.50--550.62--96.18--26.99-
Price to Book Ratio2.99-2.99-2.24-2.41-3.84-
Price-to-Total Gains Ratio37.50-37.50--550.62--96.18--26.99-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.2429
Number of shares804
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.03-0.02
Usd Total Gains Per Share0.04-0.01
Gains per Quarter (804 shares)28.51-6.66
Gains per Year (804 shares)114.04-26.63
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1249010430-56-37
24917921859-112-64
37326933289-169-91
498358446118-225-118
5122448560148-281-145
6147537674177-337-172
7171627788207-393-199
8196717902236-449-226
92208061016266-506-253
102458961130295-562-280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%13.03.00.081.3%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%6.04.00.060.0%12.04.00.075.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%6.04.00.060.0%12.04.00.075.0%

Fundamentals of Shanxi C&Y Pharmaceutical Group Co Ltd

About Shanxi C&Y Pharmaceutical Group Co Ltd

ShanXi C&Y Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of medicine and health food products. It offers anti-infective drugs, anti-allergic drugs, respiratory system drugs, urinary system drugs, kidney disease drugs, children's drugs, cardiovascular and cerebrovascular drugs, antidepressants, medicines, pharmaceutical raw materials, and intermediates, etc. The company's product portfolio includes Fosfomycin tromethamine powder, Mezlocillin sodium sulbactam sodium for injection, Ebastine tablets, Tamsulosin hydrochloride sustained release capsules, Cinacalcet hydrochloride tablets, Apixaban tablets, Rivaroxaban tablets, Flouxetine hydrochloride capsules, Ambroxol hydrochloride dispersible tablets, Smectite powder, Vitamin AD drops, and Baoling Yunbao oral liquid, as well as provides DNA gene preservation services. It also provides medical and health services and commercial services, such as medical diagnosis, gene preservation, and pregnancy environment testing services. The company was formerly known as Shanxi C&Y Pharmaceutical Co., Ltd. and changed its name to Shanxi C&Y Pharmaceutical Group Co., Ltd. in September 2014. Shanxi C&Y Pharmaceutical Group Co., LTD. was founded in 2005 and is headquartered in Datong, China.

Fundamental data was last updated by Penke on 2024-04-16 13:34:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Shanxi C&Y Pharmaceutical Group Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Shanxi C&Y Pharmaceutical Group Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Shanxi C&Y Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 3.2% means that ¥0.03 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 3.2%. The company is making a profit. +1
  • The TTM is 3.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.2%TTM3.2%0.0%
TTM3.2%YOY-14.3%+17.4%
TTM3.2%5Y-10.3%+13.4%
5Y-10.3%10Y-3.5%-6.8%
1.1.2. Return on Assets

Shows how efficient Shanxi C&Y Pharmaceutical Group Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shanxi C&Y Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.8% Return on Assets means that Shanxi C&Y Pharmaceutical Group Co Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 1.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.8%TTM1.8%0.0%
TTM1.8%YOY-7.5%+9.2%
TTM1.8%5Y-5.2%+7.0%
5Y-5.2%10Y-1.7%-3.5%
1.1.3. Return on Equity

Shows how efficient Shanxi C&Y Pharmaceutical Group Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shanxi C&Y Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.2% Return on Equity means Shanxi C&Y Pharmaceutical Group Co Ltd generated ¥0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 4.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.2%TTM4.2%0.0%
TTM4.2%YOY-20.6%+24.8%
TTM4.2%5Y-13.9%+18.1%
5Y-13.9%10Y-5.3%-8.6%

1.2. Operating Efficiency of Shanxi C&Y Pharmaceutical Group Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Shanxi C&Y Pharmaceutical Group Co Ltd is operating .

  • Measures how much profit Shanxi C&Y Pharmaceutical Group Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shanxi C&Y Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-5.4%+5.4%
5Y-5.4%10Y0.2%-5.6%
1.2.2. Operating Ratio

Measures how efficient Shanxi C&Y Pharmaceutical Group Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.28 means that the operating costs are ¥1.28 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 1.277. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.277. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.277TTM1.2770.000
TTM1.277YOY1.317-0.040
TTM1.2775Y1.334-0.058
5Y1.33410Y1.191+0.143

1.3. Liquidity of Shanxi C&Y Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Shanxi C&Y Pharmaceutical Group Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.96 means the company has ¥0.96 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 0.963. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.963. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.963TTM0.9630.000
TTM0.963YOY0.847+0.115
TTM0.9635Y1.116-0.153
5Y1.11610Y1.193-0.077
1.3.2. Quick Ratio

Measures if Shanxi C&Y Pharmaceutical Group Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shanxi C&Y Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.26 means the company can pay off ¥0.26 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 0.255. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.255. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.255TTM0.2550.000
TTM0.255YOY0.169+0.086
TTM0.2555Y0.409-0.154
5Y0.40910Y0.568-0.159

1.4. Solvency of Shanxi C&Y Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Shanxi C&Y Pharmaceutical Group Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shanxi C&Y Pharmaceutical Group Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.46 means that Shanxi C&Y Pharmaceutical Group Co Ltd assets are financed with 45.7% credit (debt) and the remaining percentage (100% - 45.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 0.457. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.457. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.457TTM0.4570.000
TTM0.457YOY0.539-0.083
TTM0.4575Y0.501-0.044
5Y0.50110Y0.421+0.080
1.4.2. Debt to Equity Ratio

Measures if Shanxi C&Y Pharmaceutical Group Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shanxi C&Y Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 109.1% means that company has ¥1.09 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 1.091. The company is able to pay all its debts with equity. +1
  • The TTM is 1.091. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.091TTM1.0910.000
TTM1.091YOY1.487-0.396
TTM1.0915Y1.264-0.173
5Y1.26410Y0.940+0.324

2. Market Valuation of Shanxi C&Y Pharmaceutical Group Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Shanxi C&Y Pharmaceutical Group Co Ltd generates.

  • Above 15 is considered overpriced but always compare Shanxi C&Y Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 92.35 means the investor is paying ¥92.35 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The EOD is 86.308. Based on the earnings, the company is expensive. -2
  • The MRQ is 92.349. Based on the earnings, the company is expensive. -2
  • The TTM is 92.349. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD86.308MRQ92.349-6.042
MRQ92.349TTM92.3490.000
TTM92.349YOY-13.802+106.151
TTM92.3495Y83.837+8.512
5Y83.83710Y142.708-58.870
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The EOD is 557.859. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 596.909. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 596.909. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD557.859MRQ596.909-39.050
MRQ596.909TTM596.9090.000
TTM596.909YOY34.013+562.896
TTM596.9095Y134.493+462.416
5Y134.49310Y0.621+133.873
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Shanxi C&Y Pharmaceutical Group Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The EOD is 2.794. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.989. Based on the equity, the company is underpriced. +1
  • The TTM is 2.989. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.794MRQ2.989-0.196
MRQ2.989TTM2.9890.000
TTM2.989YOY2.242+0.747
TTM2.9895Y2.412+0.577
5Y2.41210Y3.844-1.432
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Shanxi C&Y Pharmaceutical Group Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2020.2020%-0.062+131%-0.126+163%0.005+4222%
Book Value Per Share--3.2223.2220%3.020+7%3.359-4%3.564-10%
Current Ratio--0.9630.9630%0.847+14%1.116-14%1.193-19%
Debt To Asset Ratio--0.4570.4570%0.539-15%0.501-9%0.421+8%
Debt To Equity Ratio--1.0911.0910%1.487-27%1.264-14%0.940+16%
Dividend Per Share--0.0550.0550%0.049+12%0.067-17%0.078-29%
Eps--0.1040.1040%-0.491+570%-0.366+451%-0.132+227%
Free Cash Flow Per Share--0.0160.0160%0.199-92%0.092-82%0.032-50%
Free Cash Flow To Equity Per Share--0.0160.0160%0.199-92%0.246-93%0.200-92%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--4.797--------
Intrinsic Value_10Y_min---0.052--------
Intrinsic Value_1Y_max--0.225--------
Intrinsic Value_1Y_min--0.023--------
Intrinsic Value_3Y_max--0.872--------
Intrinsic Value_3Y_min--0.045--------
Intrinsic Value_5Y_max--1.752--------
Intrinsic Value_5Y_min--0.040--------
Market Cap2174571072.000-7%2326791047.0402326791047.0400%1635760684.160+42%1937301206.144+20%3308489076.544-30%
Net Profit Margin--0.0320.0320%-0.143+554%-0.103+426%-0.035+210%
Operating Margin----0%-0%-0.0540%0.002-100%
Operating Ratio--1.2771.2770%1.317-3%1.334-4%1.191+7%
Pb Ratio2.794-7%2.9892.9890%2.242+33%2.412+24%3.844-22%
Pe Ratio86.308-7%92.34992.3490%-13.802+115%83.837+10%142.708-35%
Price Per Share9.000-7%9.6309.6300%6.770+42%8.018+20%13.693-30%
Price To Free Cash Flow Ratio557.859-7%596.909596.9090%34.013+1655%134.493+344%0.621+96067%
Price To Total Gains Ratio35.051-7%37.50537.5050%-550.619+1568%-96.183+356%-26.992+172%
Quick Ratio--0.2550.2550%0.169+51%0.409-38%0.568-55%
Return On Assets--0.0180.0180%-0.075+525%-0.052+396%-0.017+195%
Return On Equity--0.0420.0420%-0.206+591%-0.139+431%-0.053+226%
Total Gains Per Share--0.2570.2570%-0.012+105%-0.060+123%0.082+211%
Usd Book Value--107501467.047107501467.0470%100772367.605+7%112080109.021-4%118915929.725-10%
Usd Book Value Change Per Share--0.0280.0280%-0.009+131%-0.017+163%0.001+4222%
Usd Book Value Per Share--0.4450.4450%0.417+7%0.464-4%0.492-10%
Usd Dividend Per Share--0.0080.0080%0.007+12%0.009-17%0.011-29%
Usd Eps--0.0140.0140%-0.068+570%-0.051+451%-0.018+227%
Usd Free Cash Flow--538322.837538322.8370%6641469.914-92%3058550.304-82%1066690.948-50%
Usd Free Cash Flow Per Share--0.0020.0020%0.027-92%0.013-82%0.004-50%
Usd Free Cash Flow To Equity Per Share--0.0020.0020%0.027-92%0.034-93%0.028-92%
Usd Market Cap300308265.043-7%321329843.596321329843.5960%225898550.482+42%267541296.568+20%456902341.471-30%
Usd Price Per Share1.243-7%1.3301.3300%0.935+42%1.107+20%1.891-30%
Usd Profit--3479510.5773479510.5770%-16367655.224+570%-12203425.950+451%-4403645.839+227%
Usd Revenue--110384034.775110384034.7750%114484493.232-4%125354779.882-12%120072431.777-8%
Usd Total Gains Per Share--0.0350.0350%-0.002+105%-0.008+123%0.011+211%
 EOD+4 -4MRQTTM+0 -0YOY+24 -105Y+17 -1710Y+14 -21

3.2. Fundamental Score

Let's check the fundamental score of Shanxi C&Y Pharmaceutical Group Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1586.308
Price to Book Ratio (EOD)Between0-12.794
Net Profit Margin (MRQ)Greater than00.032
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.255
Current Ratio (MRQ)Greater than10.963
Debt to Asset Ratio (MRQ)Less than10.457
Debt to Equity Ratio (MRQ)Less than11.091
Return on Equity (MRQ)Greater than0.150.042
Return on Assets (MRQ)Greater than0.050.018
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Shanxi C&Y Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.056
Ma 20Greater thanMa 509.255
Ma 50Greater thanMa 1008.730
Ma 100Greater thanMa 2008.926
OpenGreater thanClose8.800
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Operating Income  -23,266-154,651-177,917172,789-5,128-6,832-11,96048,28836,327
Net Income from Continuing Operations  -1,777-278,794-280,571206,025-74,546-23,373-97,919146,64548,726



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,433,075
Total Liabilities654,643
Total Stockholder Equity600,133
 As reported
Total Liabilities 654,643
Total Stockholder Equity+ 600,133
Total Assets = 1,433,075

Assets

Total Assets1,433,075
Total Current Assets406,549
Long-term Assets1,026,527
Total Current Assets
Cash And Cash Equivalents 132,004
Net Receivables 107,802
Inventory 120,831
Other Current Assets 15,462
Total Current Assets  (as reported)406,549
Total Current Assets  (calculated)376,099
+/- 30,450
Long-term Assets
Property Plant Equipment 297,520
Goodwill 316,254
Intangible Assets 208,796
Long-term Assets Other 5,990
Long-term Assets  (as reported)1,026,527
Long-term Assets  (calculated)828,561
+/- 197,966

Liabilities & Shareholders' Equity

Total Current Liabilities422,366
Long-term Liabilities232,277
Total Stockholder Equity600,133
Total Current Liabilities
Short Long Term Debt 67,432
Accounts payable 36,790
Other Current Liabilities 9,536
Total Current Liabilities  (as reported)422,366
Total Current Liabilities  (calculated)113,757
+/- 308,609
Long-term Liabilities
Long term Debt 139,900
Capital Lease Obligations Min Short Term Debt18,885
Long-term Liabilities Other 6,717
Long-term Liabilities  (as reported)232,277
Long-term Liabilities  (calculated)165,503
+/- 66,774
Total Stockholder Equity
Total Stockholder Equity (as reported)600,133
Total Stockholder Equity (calculated)0
+/- 600,133
Other
Capital Stock241,619
Common Stock Shares Outstanding 241,619
Net Debt 75,328
Net Invested Capital 807,464
Net Working Capital -15,818
Property Plant and Equipment Gross 594,068



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
> Total Assets 
224,154
259,509
280,838
702,565
827,159
1,090,371
1,181,338
1,308,431
1,432,590
1,518,593
1,495,710
1,802,029
1,800,519
1,526,809
1,584,408
1,433,075
1,433,0751,584,4081,526,8091,800,5191,802,0291,495,7101,518,5931,432,5901,308,4311,181,3381,090,371827,159702,565280,838259,509224,154
   > Total Current Assets 
0
0
0
0
0
0
0
491,010
533,968
602,787
634,862
648,184
578,909
375,891
508,026
406,549
406,549508,026375,891578,909648,184634,862602,787533,968491,0100000000
       Cash And Cash Equivalents 
6,249
95,718
80,509
395,102
300,063
108,467
134,312
217,956
158,252
151,497
147,685
143,349
188,437
107,255
263,946
132,004
132,004263,946107,255188,437143,349147,685151,497158,252217,956134,312108,467300,063395,10280,50995,7186,249
       Short-term Investments 
0
0
0
0
0
389
21,760
0
0
0
0
0
0
0
0
0
00000000021,76038900000
       Net Receivables 
79,424
15,036
7,108
48,624
135,052
127,204
140,693
185,030
259,281
308,398
315,596
338,407
197,478
142,760
101,377
107,802
107,802101,377142,760197,478338,407315,596308,398259,281185,030140,693127,204135,05248,6247,10815,03679,424
       Other Current Assets 
2,658
2,974
2,443
31,775
932
2,558
6,879
7,411
19,566
14,512
40,657
27,383
32,452
17,491
3,251
15,462
15,4623,25117,49132,45227,38340,65714,51219,5667,4116,8792,55893231,7752,4432,9742,658
   > Long-term Assets 
0
0
0
0
0
0
0
0
898,622
915,807
860,848
1,153,845
1,221,609
1,150,918
1,076,381
1,026,527
1,026,5271,076,3811,150,9181,221,6091,153,845860,848915,807898,62200000000
       Property Plant Equipment 
73,509
68,953
108,176
137,414
171,656
497,335
364,040
347,789
353,836
397,396
389,694
363,833
398,676
386,140
356,417
297,520
297,520356,417386,140398,676363,833389,694397,396353,836347,789364,040497,335171,656137,414108,17668,95373,509
       Goodwill 
0
0
0
0
0
0
235,510
225,826
216,976
205,864
164,664
142,545
359,533
339,933
320,354
316,254
316,254320,354339,933359,533142,545164,664205,864216,976225,826235,510000000
       Long Term Investments 
0
0
0
0
0
0
0
58,335
93,377
82,647
79,778
0
0
0
0
0
0000079,77882,64793,37758,3350000000
       Intangible Assets 
26,884
30,693
24,813
21,350
47,338
48,799
316,671
81,187
145,398
128,844
124,463
120,247
258,376
235,231
222,628
208,796
208,796222,628235,231258,376120,247124,463128,844145,39881,187316,67148,79947,33821,35024,81330,69326,884
       Long-term Assets Other 
0
0
0
0
0
0
0
0
481
4,283
369
1,504
8,295
5,694
926
5,990
5,9909265,6948,2951,5043694,28348100000000
> Total Liabilities 
117,452
141,906
131,252
121,392
175,992
323,212
358,175
435,934
477,740
547,419
564,470
869,427
927,906
782,229
854,702
654,643
654,643854,702782,229927,906869,427564,470547,419477,740435,934358,175323,212175,992121,392131,252141,906117,452
   > Total Current Liabilities 
77,452
121,906
131,252
121,392
169,268
207,824
232,288
262,627
328,937
476,253
398,552
393,214
489,899
400,029
599,678
422,366
422,366599,678400,029489,899393,214398,552476,253328,937262,627232,288207,824169,268121,392131,252121,90677,452
       Short-term Debt 
0
0
0
0
0
0
0
20,000
108,000
135,000
129,000
0
0
0
0
0
00000129,000135,000108,00020,0000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
20,000
108,000
135,000
129,000
99,156
100,531
91,032
57,672
67,432
67,43257,67291,032100,53199,156129,000135,000108,00020,0000000000
       Accounts payable 
28,348
34,147
37,116
47,374
23,527
37,107
43,658
50,329
52,398
85,411
68,709
69,096
68,218
47,355
40,889
36,790
36,79040,88947,35568,21869,09668,70985,41152,39850,32943,65837,10723,52747,37437,11634,14728,348
       Other Current Liabilities 
49,104
47,759
34,136
34,018
68,241
117,717
128,630
96,752
76,249
61,789
101,236
156,016
163,534
140,095
7,342
9,536
9,5367,342140,095163,534156,016101,23661,78976,24996,752128,630117,71768,24134,01834,13647,75949,104
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
148,803
71,167
165,919
476,212
438,008
382,200
255,024
232,277
232,277255,024382,200438,008476,212165,91971,167148,80300000000
       Other Liabilities 
0
0
0
0
0
1,930
30,235
43,307
48,803
40,967
38,319
258,128
331,448
343,219
0
0
00343,219331,448258,12838,31940,96748,80343,30730,2351,93000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
14,237
19,183
18,900
33,634
32,345
5,086
15,666
0
0
0015,6665,08632,34533,63418,90019,18314,2370000000
> Total Stockholder Equity
106,702
117,602
149,586
581,172
596,269
610,002
637,619
785,998
808,655
819,586
799,092
815,886
687,099
589,406
574,937
600,133
600,133574,937589,406687,099815,886799,092819,586808,655785,998637,619610,002596,269581,172149,586117,602106,702
   Common Stock
100,000
100,000
100,000
133,800
133,800
133,800
133,800
173,590
208,308
208,308
208,308
208,308
227,971
227,971
0
0
00227,971227,971208,308208,308208,308208,308173,590133,800133,800133,800133,800100,000100,000100,000
   Retained Earnings 
3,183
11,193
29,426
61,236
74,838
86,363
125,913
135,433
156,901
168,159
164,985
181,772
-80,596
-172,033
-308,545
-283,350
-283,350-308,545-172,033-80,596181,772164,985168,159156,901135,433125,91386,36374,83861,23629,42611,1933,183
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
67
0
0
0
0
0
0
0
00000006700000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue799,305
Cost of Revenue-257,473
Gross Profit541,832541,832
 
Operating Income (+$)
Gross Profit541,832
Operating Expense-762,978
Operating Income36,327-221,146
 
Operating Expense (+$)
Research Development49,970
Selling General Administrative364,230
Selling And Marketing Expenses0
Operating Expense762,978414,201
 
Net Interest Income (+$)
Interest Income3,743
Interest Expense-33,159
Other Finance Cost-134
Net Interest Income-29,550
 
Pretax Income (+$)
Operating Income36,327
Net Interest Income-29,550
Other Non-Operating Income Expenses0
Income Before Tax (EBT)55,27936,327
EBIT - interestExpense = -33,159
25,196
58,354
Interest Expense33,159
Earnings Before Interest and Taxes (EBIT)088,438
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax55,279
Tax Provision-6,553
Net Income From Continuing Ops48,72648,726
Net Income25,196
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net029,550
 

Technical Analysis of Shanxi C&Y Pharmaceutical Group Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shanxi C&Y Pharmaceutical Group Co Ltd. The general trend of Shanxi C&Y Pharmaceutical Group Co Ltd is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shanxi C&Y Pharmaceutical Group Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shanxi C&Y Pharmaceutical Group Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 11.60.

The bearish price targets are: 7.69 > 7.01 > 4.98.

Tweet this
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shanxi C&Y Pharmaceutical Group Co Ltd. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shanxi C&Y Pharmaceutical Group Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shanxi C&Y Pharmaceutical Group Co Ltd. The current macd is -0.15315128.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Shanxi C&Y Pharmaceutical Group Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Shanxi C&Y Pharmaceutical Group Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Shanxi C&Y Pharmaceutical Group Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shanxi C&Y Pharmaceutical Group Co Ltd. The current adx is 20.59.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Shanxi C&Y Pharmaceutical Group Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shanxi C&Y Pharmaceutical Group Co Ltd. The current sar is 9.97633002.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shanxi C&Y Pharmaceutical Group Co Ltd. The current rsi is 51.06. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shanxi C&Y Pharmaceutical Group Co Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shanxi C&Y Pharmaceutical Group Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Stochastic Oscillator ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shanxi C&Y Pharmaceutical Group Co Ltd. The current cci is -18.67523286.

Shanxi C&Y Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shanxi C&Y Pharmaceutical Group Co Ltd. The current cmo is 6.12155078.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shanxi C&Y Pharmaceutical Group Co Ltd. The current willr is -57.18954248.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Shanxi C&Y Pharmaceutical Group Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Williams %R ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shanxi C&Y Pharmaceutical Group Co Ltd.

Shanxi C&Y Pharmaceutical Group Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shanxi C&Y Pharmaceutical Group Co Ltd. The current atr is 0.67653716.

Shanxi C&Y Pharmaceutical Group Co Ltd Daily Average True Range (ATR) ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shanxi C&Y Pharmaceutical Group Co Ltd. The current obv is 126,301,235.

Shanxi C&Y Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shanxi C&Y Pharmaceutical Group Co Ltd. The current mfi is 56.21.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shanxi C&Y Pharmaceutical Group Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Shanxi C&Y Pharmaceutical Group Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shanxi C&Y Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.056
Ma 20Greater thanMa 509.255
Ma 50Greater thanMa 1008.730
Ma 100Greater thanMa 2008.926
OpenGreater thanClose8.800
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Shanxi C&Y Pharmaceutical Group Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Shanxi C&Y Pharmaceutical Group Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shanxi C&Y Pharmaceutical Group Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shanxi C&Y Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Shanxi C&Y Pharmaceutical Group Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Shanxi C&Y Pharmaceutical Group Co Ltd.

Receive notifications about Shanxi C&Y Pharmaceutical Group Co Ltd in your mailbox!